Oncopeptides has completed a directed share issue of SEK 314 million 22.03.18 News Share: Facebook Twitter LinkedIn Oncopeptides today announces that the company has successfully completed a directed share issue of approximately SEK 314 million (USD 38 million). > Read the full press release here ← Next post Previous post →